Evidence Synthesis
NurecA's 37.75% gross margin accelerated to, up from 7.15%.
The company's .15% marginal operating leverage also accelerated. This contrasts with a decelerating to . The close price .5 INR.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 24 Aug 2026, 04:53
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
NurecA's 37.75% gross margin accelerated to, up from 7.15%.
The company's .15% marginal operating leverage also accelerated. This contrasts with a decelerating to . The close price .5 INR.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 37.75 % | 7.15 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 7.15 % | 2.83 | ▲ |
| REVENUE_GROWTH_YOY | 18 % | 296.3 | ▼ |
| PRICE_CHANGE_PERCENT | -4.538 % | — | - |
| DAILY_VOLUME | 6,550 shares | 37,513 | ▼ |
| CLOSE_PRICE | 305 INR | 319.5 | ▼ |